Gabelli & Co Investment Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Hold
1,000
– – 0.04% 232
2026
Q1
$244K Hold
1,000
– – 0.04% 217
2025
Q4
$207K Buy
+1,000
New +$198K 0.03% 219
2025
Q3
– Sell
-1,500
Closed -$229K – 308
2025
Q2
$229K Hold
1,500
– – 0.04% 206
2025
Q1
$249K Sell
1,500
-500
-25% -$78.2K 0.04% 182
2024
Q4
$289K Hold
2,000
– – 0.05% 166
2024
Q3
$324K Hold
2,000
– – 0.06% 129
2024
Q2
$292K Hold
2,000
– – 0.05% 161
2024
Q1
$316K Buy
2,000
+500
+33% +$79.6K 0.06% 145
2023
Q4
$235K Hold
1,500
– – 0.04% 167
2023
Q3
$234K Hold
1,500
– – 0.04% 166
2023
Q2
$248K Buy
+1,500
New +$242K 0.04% 157

Other funds holding JNJ

Gabelli & Co Investment Advisers's JNJ Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its Johnson & Johnson (JNJ) position steady in Q2 2026 at 1,000 shares worth $254K. The position accounts for 0.04% of the portfolio, ranked #232.

Gabelli & Co Investment Advisers first reported a position in JNJ in Q2 2023 and has held it in 12 quarters since. The position peaked at $324K in Q3 2024. 4,698 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Gabelli & Co Investment Advisers held 1,000 shares of Johnson & Johnson worth $254K as of Q2 2026.
  • Gabelli & Co Investment Advisers left its Johnson & Johnson share count unchanged in Q2 2026.
  • Johnson & Johnson made up 0.04% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #232 holding.
  • Gabelli & Co Investment Advisers first reported a position in Johnson & Johnson in Q2 2023 and has held it in 12 quarters since.
  • Gabelli & Co Investment Advisers's Johnson & Johnson position peaked at $324K in Q3 2024.
  • 4,698 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.